Clinical cancer research in the U.S. is increasingly dominated by pharmaceutical industry sponsors, study finds
Fred Hutchinson Cancer CenterResearchers at Fred Hutch Cancer Center identified a substantial increase over the past decade in the proportion of patients with cancer in the U.S. who participate in pharmaceutical industry sponsored clinical trials compared to those conducted with federal government support. Published in The Journal of Clinical Oncology and presented at the ASCO Quality Care Symposium, these findings reveal trends of underinvestment in federally funded studies, flat enrollment counts in federally funded studies over more than a decade and a growing reliance on industry to conduct cancer research.